Last Updated: September 29, 2026

Pentetate zinc trisodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for pentetate zinc trisodium and what is the scope of patent protection?

Pentetate zinc trisodium is the generic ingredient in one branded drug marketed by Hameln Pharma Plus and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for pentetate zinc trisodium
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 9
Clinical Trials: 1
Patent Applications: 97
What excipients (inactive ingredients) are in pentetate zinc trisodium?pentetate zinc trisodium excipients list
DailyMed Link:pentetate zinc trisodium at DailyMed
Recent Clinical Trials for pentetate zinc trisodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1/Phase 2

See all pentetate zinc trisodium clinical trials

US Patents and Regulatory Information for pentetate zinc trisodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hameln Pharma Plus PENTETATE ZINC TRISODIUM pentetate zinc trisodium SOLUTION;INHALATION, INTRAVENOUS 021751-001 Aug 11, 2004 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.